19 May 2023 in Brazilian Journal of Analytical Chemistry
Metabolomics has become a prominent area within the omics sciences and allows an understanding of complex biological systems. Among several areas of knowledge, the study of microorganisms (microbial metabolomics) has received attention. Due to the many species of microorganisms and their high metabolic complexity, many challenges are involved in metabolomics workflow. Careful experimental design and execution of the experiments will provide reliable results, allowing correct biological interpretation. This review presents the fundamentals of metabolomics and workflow, focusing on the description of the steps and analytical strategies applied to microbial sample preparation, highlighting the current challenges in sample handling. In addition, the state of the art of analytical technologies based on separation techniques hyphenated to mass spectrometry and applications in microbial metabolomics are presented.
17 April 2026 in Metabolomics
Background and aims: The development of breast cancer exhibits a heterogeneous and complex character in both felines and humans, which motivates the search for serum biomarkers for diagnosis, prognosis, and therapeutic monitoring. Although the feline species is recognized as a relevant comparative model for human breast cancer, metabolomic studies in cats are still scarce. This work aimed to investigate altered serum metabolites involved in feline mammary carcinoma (FMC). Methods: Serum samples from 28 adult female cats (11 healthy and 17 with malignant mammary tumors undergoing mastectomy) were evaluated. The samples were extracted with pure methanol and derivatized (oximation followed by silylation) for GC–MS analysis. Results: Twenty-six metabolites or chemical classes were found significantly altered. The main alteration was related to the metabolism of amino acids, carbohydrates, and the tricarboxylic acid cycle, mostly with reduced serum levels in female cancer patients, suggesting high tumor uptake. Analysis of metabolic pathways revealed alterations in the metabolism of alanine, aspartate, and glutamate; arginine and proline; starch and sucrose; and butanoate metabolism. Conclusions: These findings provide preliminary evidence supporting the determination of candidate biomarkers and the mapping of disrupted metabolic pathways in FMC. Validation of the study and confirmation of the metabolite’s structural identity are critical to enable robust comparative studies and to direct the development of innovative diagnostic and therapeutic strategies.
20 November 2025 in ACS Infectious Diseases
MNMaria Vitória Gomes das Neves
Maria Vitória Gomes das Neves
MSMaria Gabriela Sarah Santos
Maria Gabriela Sarah Santos
CCCarine Machado Azevedo Cardoso
Carine Machado Azevedo Cardoso
+2
Chagas disease (CD), caused by Trypanosoma cruzi, has been one of the leading causes of cardiac death in Latin America. Its pathogenesis and progression are still poorly understood. Thus, we performed an untargeted metabolomics analysis to understand the metabolic changes involved in the final acute phase of CD. Male mice's chagasic hearts (60 days postinfection) were compared to healthy tissues. Two hundred and fifty-one significant metabolites or chemical classes were annotated. Disturbances in energy metabolism and dysregulation of amino acids were observed. Pathway analyses indicated increased inflammatory activity in infected individuals, as observed by eicosanoid (prostaglandin and thromboxane) changes. The accumulation of some sphingomyelins, correlated with myocarditis, suggests heart tissue damage from the infection. The metabolic changes observed contribute to understanding disease progression and the cardiac effects caused by the parasite, bringing new insights into the discovery and development of new therapies.
1 January 2026 in Journal of the Brazilian Chemical Society
Untargeted metabolomics data are highly complex and variable. One of the major challenges in processing them is ensuring that biological interpretations reflect the organism metabolic variability rather than undesirable factors arising from random or systematic experimental errors. Here, nine post-acquisition normalization strategies were evaluated on two gas chromatography-mass spectrometry (GC-MS) metabolomics datasets (cellular and serum). GC-MS data are particularly affected by experimental variability since derivatization steps are required. Thus, the use of internal standards (IS) is indicated, although not mandatory. When an IS is not available, post-acquisition normalization methods help correct for variations. Mean, median, and EigenMS normalization proved quite suitable for both datasets, as evidenced by good sample and quality control grouping and within-group relative log abundance (RLA). EigenMS was chosen due to its improved sample grouping. Strategies that use a sample as a reference factor for normalization did not demonstrate the same efficiency, as they introduced biases into the multivariate models. This could be due to a poor choice of reference sample, which compromises the fit of the data matrix. The results observed in this study demonstrate the importance of testing different normalization methods in any metabolomics study to help obtain more robust and reliable matrices for data inspection and interpretation.
8 September 2026 in Analytica Chimica Acta
ÉRÉmile Graciane Mendonça Reis
Émile Graciane Mendonça Reis
In metabolomics studies, biological data are highly complex, requiring robust computational tools to detect biological variation in the organism under investigation. Despite this, comparative studies of data processing software for GC-MS data are scarce. This work evaluated the performance of two open-source software programs, XCMS and MS-DIAL, on three datasets: cells, serum, and tissue, acquired by GC-MS. Software performance was assessed based on the quality of the raw data matrix, the number of extracted features, the presence of missing values, and the number of annotated metabolites or chemical classes. Overall, both tools produced robust matrices and adequate statistical models, with high similarity in the regulation of common metabolites. For the investigated datasets, XCMS demonstrated slightly better performance in raw matrix quality, while MS-DIAL showed a higher correlation with the annotations. The combination of matrices broadened metabolic coverage, allowing for improvements in supervised statistical models. The choice of data processing platform and the parameters used directly impact the extracted data matrix and the conclusions regarding metabolic alterations. These observations reinforce the need for careful evaluation in metabolomics analyses, so that selection involves not only parameters such as the number of features and metabolites obtained, but also the method's stability and its ability to show the chemical variability of the analyzed biological system.